Network-targeted neurophysiological biomarkers of dysconnectivity and cognitive decline in Alzheimer’s disease
TL;DR
These network-specific, hemisphere-sensitive measures may serve as biomarkers for diagnosis, tracking, and prognosis of cognitive decline, and could inform personalized network-targeted neuromodulation in AD.
Abstract
Alzheimer’s disease (AD) is marked by progressive network disconnection that begins decades before symptoms emerge, yet detecting early functional disruptions remains a key challenge. Transcranial magnetic stimulation combined with electroencephalography (TMS–EEG) provides a direct, non-invasive probe of cortical dynamics and may yield biomarkers that index cortical network dysfunction, track progression, and inform personalized neuromodulation strategies. We enrolled 86 participants: 28 HC (mean age 69.7 ± 6.0, 15 female), 27 MCI (73.1 ± 5.2, 16 female), and 31 ADD (75.8 ± 4.9, 17 female). TMS–EEG targeted individualized default mode (DMN) and executive control (ECN) network nodes identified via resting-state fMRI. Using a data-driven strategy, we extracted early TMS-evoked potential (TEP) components within 50 ms. We assessed group differences, associations with hippocampal volume, white matter integrity, and cognition, and prediction of cognitive decline over ~ 1.5 years ( n = 55). After left DMN stimulation, the contralateral frontal N20F peak was increased in both MCI (P-adj. = 0.0001, Δ = 1.89 µV) and ADD (P-adj. = 0.0003, Δ = 1.76 µV) relative to HC, achieving an AUC of 0.82 for HC-versus-MCI classification. In the ECN, N20C amplitude showed a diagnosis-by-hemisphere interaction: reduced in MCI after left stimulation (P-adj. = 0.036, Δ = −13.64 µV) but increased in MCI and ADD after right stimulation (P-adj. = 0.028, Δ = 14.59 µV and P-adj. = 0.048, Δ = 10.30 µV). Left DMN N20C amplitude correlated with superior longitudinal fasciculus integrity ( P = 0.009, β = 37.15). TEPs were selectively linked to executive function: in ADD, larger left ECN N20F predicted worse Trail Making Test scores (P-adj. = 0.0003, β = −24.35). Longitudinally, lower left DMN N20C predicted steeper global cognitive decline (β = 0.74, P = 0.014), and right ECN N20C predicted executive decline in MCI (β = −35.15, P = 0.0004). Early network-targeted TEPs capture functional alterations linked to AD progression. Limitations include the moderate sample size, clinical rather than biomarker-confirmed diagnosis, and single-site design. These network-specific, hemisphere-sensitive measures may serve as biomarkers for diagnosis, tracking, and prognosis of cognitive decline, and could inform personalized network-targeted neuromodulation in AD. Not applicable (observational study).